Publications found:
73,128
Sort by:
Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,370.00
Continuous Glucose Monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM systems are a type of glucose monitoring devices that ... the competitive outlook of the global CGMS market KEY MARKET SEGMENTS The CGMS market is segmented based on components, customer ...
April 2020
267 pages
Global Coronary Stent Market Size study, by Type (Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents) By Material ( Metallic Stents, Other Stents), By End User ( Hospitals, Cardiac Centers, Ambulatory Surgical Centers) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Coronary Stent Market is valued approximately at USD 8.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2019-2026.Coronary sten...
April 2020
200 pages
Casimersen - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Casimersen - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
Idebenone - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Idebenone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product f...
April 2020
60 pages
PF-06939926 - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “PF-06939926 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
SAGE-217 - Emerging Insight and Market Forecast – 2028
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “SAGE-217 - Emerging Insight and Market Forecast – 2028” the report provides comprehensive insights about an investigational product fo...
April 2020
60 pages
SRP-9001 - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “SRP-9001 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
April 2020
60 pages
Vamorolone - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Vamorolone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
Global Dietary Supplements Market Outlook 2028
US$ 4,150.00
Global Dietary Supplements Market Analysis – 2019-2028 Dietary supplements are essential nutrients present as various dosage forms such as tablets, capsules, soft gels and others, and are derived from...
April 2020
566 pages
Global Myopia and Presbyopia Treatment Market Outlook 2028
US$ 4,150.00
Global Myopia and Presbyopia Treatment Market Analysis – 2019-2028 Myopia is a condition of the eye which is characterized by unclear vision while seeing objects at a distance while presbyopia is the...
April 2020
112 pages
Burn Care Market by Product (Advanced Burn Care, Biologics, Traditional Burn Care, and Others), Depth of Burn (Minor Burns, Partial-thickness Burns, and Full-thickness Burns), and End User (Hospitals, Physician Offices, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,370.00
The burn care market was valued at $1,992 million in 2019, and is estimated to reach at $3,134 million by 2027, registering a CAGR of 5.6% from 2020 to 2027. Burn is an injury to tissue or skin caused...
April 2020
251 pages
Egypt Medical Bandage Market by Product (Gauze Bandage, Adhesive Bandage, Cohesive Bandages and Elastic Bandages), Application (Surgical Wounds, Traumatic and Laceration Wounds,Burns, Ulcers, Sport Injuries, and Others), and End-User (Hospital, Clinics, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2019–2026
US$ 2,175.00
The Egypt medical bandages market was valued at $14.38 million in 2018 and is expected to reach $19.12 million by 2026, registering a CAGR of 3.6% from 2019 to 2026. Medical bandages are a piece of ma...
April 2020
86 pages
Europe Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), andOthers),Product Type (Software and Device), and Sales Channel (Business-to-Business(B2B) and Business-to-Consumer (B2C)): Opportunity Analysis and Industry Forecast, 2019–2026
US$ 3,850.00
The Europe digital therapeutics market was valued at $503.48 million in 2018 and is expected to reach $2,274.03 million by 2026 with a CAGR of 20.6% during the forecast period. Digital therapeutics pr...
April 2020
159 pages
Life Science Analytics Software Market by Product (Descriptive Analytics, Prescriptive Analytics, and Predictive Analytics), Application (Research & Development, Sales & Marketing Support, Regulatory Compliance, Supply Chain Analytics, and Pharmacovigilance), Delivery Model (On-Premise and Cloud), and End User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers and Third-Party Administrators): Global Opportunity Analysis and Industry Forecast, 2020-2027
US$ 5,370.00
The global life science analytics software market size in 2019 was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.The life sciences industr...
April 2020
289 pages
Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2018–2026
US$ 5,370.00
The global meningococcal vaccine market was valued at $1,935.5 million in 2018, and is projected to reach $4,192.5 million by 2026, registering a CAGR of 9.5% from 2019 to 2026. Invasive meningococcal...
April 2020
197 pages
mHealth Market by Type (mHealth Devices and mHealth Services), Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers, and Content Players), and Application (Cardiovascular Diseases, Diabetes, Respiratory diseases, Neurological Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,370.00
The mHealth market accounted for $46,048 million in 2019, and is expected to reach $230,419 million by 2027, registering a CAGR of 22.3% from 2020 to 2027. Electronic health (eHealth) is defined as co...
April 2020
362 pages
Saudi Arabia Medical Bandages Market by Product (Gauze Bandage, Adhesive Bandage, Cohesive Bandage, and Elastic Bandage),Application (Surgical Wounds, Traumatic &Laceration Wounds, Burns, Ulcer, Sports Injuries, and Other Wounds), and End User (Hospitals, Clinics, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The Saudi Arabia medical bandages market accounted for $136 million in 2018, and is expected to reach $213 million by 2026, registering a CAGR of 5.7% from 2019 to 2026. Medical bandages are defined a...
April 2020
123 pages
VR in Healthcare Market by Product (VR Semiconductor Components, VR Devices, VR Sensors, and Others), Technology (Head-Mounted Technology, Gesture-Tracking Technology, and Projector & Display Walls Technology), and End User (Hospitals &Clinics, Research Laboratories, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2019-2026
US$ 5,370.00
The global VR in healthcare market was valued at $240.91 million in 2018 and is projected to reach $2,383.68 million by 2026, registering a CAGR of 33.18% from 2019 to 2026. Virtual reality is one of...
April 2020
201 pages
Uveitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
259 pages
Celiac Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Celiac Disease (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Celiac Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
85 pages
Glaucoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Glaucoma (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
359 pages
Hepatitis C - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis C (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
414 pages
Herpes Zoster (Shingles) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Herpes Zoster (Shingles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Zoster (Shingles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
69 pages
Malignant Mesothelioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malignant Mesothelioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Malignant Mesothelioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1024 pages
Myocardial Infarction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
362 pages
Peritoneal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peritoneal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Peritoneal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1595 pages
Pyelonephritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pyelonephritis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pyelonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
134 pages
Women Infertility - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
217 pages
Chemotherapy Induced Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Anemia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
63 pages
Dyskinesia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Dyskinesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dyskinesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
249 pages
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graft Versus Host Disease (GVHD) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Graft Versus Host Disease (GVHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
725 pages
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratoconjunctivitis sicca (Dry Eye) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
320 pages
Neutropenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
133 pages
Opium (Opioid) Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Opium (Opioid) Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Opium (Opioid) Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
161 pages
Psoriasis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Psoriasis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
935 pages
Tetanus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tetanus (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tetanus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
94 pages
Acromegaly - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
103 pages
Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Deep Vein Thrombosis (DVT) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
35 pages
Glomerulonephritis - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
303 pages
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Post-Polycythemia Vera Myelofibrosis (PPV-MF) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
364 pages
Depression - Pipeline Review, H1 2020
US$ 2,000.00
... . The Depression (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Depression and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
668 pages
Mild Cognitive Impairment - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mild Cognitive Impairment (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Mild Cognitive Impairment and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
125 pages
